{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T21:28:17Z","timestamp":1790112497369,"version":"4.0.1"},"reference-count":90,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.lpm.2017.10.007","type":"journal-article","created":{"date-parts":[[2017,11,23]],"date-time":"2017-11-23T04:45:33Z","timestamp":1511412333000},"page":"e296-e305","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"special_numbering":"P2","title":["Iron overload in hematological disorders"],"prefix":"10.1016","volume":"46","author":[{"given":"Eitan","family":"Fibach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliezer A.","family":"Rachmilewitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lpm.2017.10.007_bib0455","doi-asserted-by":"crossref","first-page":"609","DOI":"10.2174\/156652408786241384","article-title":"The role of oxidative stress in hemolytic anemia","volume":"8","author":"Fibach","year":"2008","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.lpm.2017.10.007_bib0460","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1159\/000258958","article-title":"Effect of iron chelators on labile iron and oxidative status of thalassaemic erythroid cells","volume":"123","author":"Prus","year":"2010","journal-title":"Acta Haematol"},{"key":"10.1016\/j.lpm.2017.10.007_bib0465","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1749-6632.2010.05577.x","article-title":"The role of antioxidants and iron chelators in the treatment of oxidative stress in thalassemia. Cooley's Anemia: Ninth Symposium","volume":"1202","author":"Fibach","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.lpm.2017.10.007_bib0470","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.leukres.2012.04.030","article-title":"Selective toxicity towards myelodysplastic hematopoietic progenitors\u2014Another rationale for iron chelation in MDS","volume":"36","author":"Fibach","year":"2012","journal-title":"Leukemia Res"},{"key":"10.1016\/j.lpm.2017.10.007_bib0475","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0037-1963(01)90028-9","article-title":"Pathophysiology of alpha- and beta-thalassemia: therapeutic implications","volume":"38","author":"Rund","year":"2001","journal-title":"Semin Hematol"},{"key":"10.1016\/j.lpm.2017.10.007_bib0480","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0037-1963(01)90023-X","article-title":"Pathophysiology of sickle cell disease: role of cellular and genetic modifiers","volume":"38","author":"Steinberg","year":"2001","journal-title":"Semin Hematol"},{"key":"10.1016\/j.lpm.2017.10.007_bib0485","doi-asserted-by":"crossref","DOI":"10.1111\/bjh.14575","article-title":"How we manage iron overload in sickle cell patients","author":"Coates","year":"2017","journal-title":"Br J Haematol"},{"key":"10.1016\/j.lpm.2017.10.007_bib0490","first-page":"217","article-title":"Glucose-6-phosphate-dehydrogenase","volume":"14","author":"Luzzatto","year":"1985","journal-title":"Adv Hum Genet"},{"key":"10.1016\/j.lpm.2017.10.007_bib0495","doi-asserted-by":"crossref","first-page":"10609","DOI":"10.1074\/jbc.273.17.10609","article-title":"Importance of glucose-6-phosphate dehydrogenase activity for cell growth","volume":"273","author":"Tian","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.lpm.2017.10.007_bib0500","doi-asserted-by":"crossref","first-page":"5209","DOI":"10.1002\/j.1460-2075.1995.tb00205.x","article-title":"Targeted disruption of the housekeeping gene encoding glucose-6-phosphate-dehydrogenase (G6pd)\u00a0-\u00a0G6pd is dispensable for pentose synthesis but essential for defense against oxidative stress","volume":"14","author":"Pandolfi","year":"1995","journal-title":"Embo J"},{"key":"10.1016\/j.lpm.2017.10.007_bib0505","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1007\/s12185-016-1990-6","article-title":"Iron overload, G6PD deficiency, and lead levels on blood smears","volume":"103","author":"Pigatto","year":"2016","journal-title":"Int J Hematol"},{"key":"10.1016\/j.lpm.2017.10.007_bib0510","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/j.1432-1033.1990.tb19406.x","article-title":"Radiolabel-transfer cross-linking demonstrates that protein-4.1 binds to the N-terminal region of beta-spectrin and to actin in binary interactions","volume":"193","author":"Becker","year":"1990","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.lpm.2017.10.007_bib0515","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1182\/blood.V77.1.165.165","article-title":"Molecular-basis of spectrin and ankyrin deficiencies in severe hereditary spherocytosis\u00a0\u2013\u00a0Evidence implicating a primary defect of ankyrin","volume":"77","author":"Hanspal","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.lpm.2017.10.007_bib0520","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0140-6736(68)90648-X","article-title":"Hereditary spherocytosis with secondary hemochromatosis","volume":"ii","author":"Barry","year":"1968","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2017.10.007_bib0525","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1365-2141.2005.05757.x","article-title":"Advances in the understanding of the congenital dyserythropoietic anaemias","volume":"131","author":"Wickramasinghe","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.lpm.2017.10.007_bib0530","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1086\/344781","article-title":"Congenital dyserythropoietic anemia type I is caused by mutations in codanin-1","volume":"71","author":"Dgany","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.lpm.2017.10.007_bib0535","series-title":"Congenital dyserythropoietic anemia type I","first-page":"1993","author":"Tamary","year":"2009"},{"key":"10.1016\/j.lpm.2017.10.007_bib0540","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1532\/IJH97.06117","article-title":"Recent advances in biological and clinical aspects of paroxysmal nocturnal hemoglobinuria","volume":"84","author":"Luzzatto","year":"2006","journal-title":"Int J Hematol"},{"key":"10.1016\/j.lpm.2017.10.007_bib0545","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1182\/blood.V98.2.442","article-title":"Targeted deletion of the CD59 gene causes spontaneous intravascular hemolysis and hemoglobinuria","volume":"98","author":"Holt","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.lpm.2017.10.007_bib0550","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.exphem.2007.01.046","article-title":"The pathophysiology of paroxysmal nocturnal hemoglobinuria","volume":"35","author":"Parker","year":"2007","journal-title":"Exp Hematol"},{"key":"10.1016\/j.lpm.2017.10.007_bib0555","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1365-2141.2012.09094.x","article-title":"Aplastic anaemia and PNH transformation with deposition of liver iron","volume":"157","author":"Gooneratne","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.lpm.2017.10.007_bib0560","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.mcna.2016.09.007","article-title":"Autoimmune hemolytic anemia","volume":"101","author":"Liebman","year":"2017","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.lpm.2017.10.007_bib0565","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1651-2227.1984.tb09916.x","article-title":"Autoimmune hemolytic-anemia treated with multiple transfusions, immunosuppressive therapy, plasma-exchange, and desferrioxamine","volume":"73","author":"Andersen","year":"1984","journal-title":"Acta Paediatr Scand"},{"key":"10.1016\/j.lpm.2017.10.007_bib0570","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00277-010-1091-1","article-title":"Iron overload in MDS-pathophysiology, diagnosis, and complications","volume":"90","author":"Gattermann","year":"2011","journal-title":"Ann Hematol"},{"key":"10.1016\/j.lpm.2017.10.007_bib0575","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1182\/blood-2012-05-430876","article-title":"SF3B1 haploinsufficiency leads to formation of ring sideroblasts in myelodysplastic syndromes","volume":"120","author":"Visconte","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.lpm.2017.10.007_bib0580","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.critrevonc.2017.03.002","article-title":"Toxicity of iron overload and iron overload reduction in the setting of hematopoietic stem cell transplantation for hematologic malignancies","volume":"113","author":"Leitcha","year":"2017","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.lpm.2017.10.007_bib0585","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0092-8674(04)00343-5","article-title":"Balancing acts: molecular control of mammalian iron metabolism","volume":"117","author":"Hentze","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.lpm.2017.10.007_bib0590","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1053\/j.seminhematol.2005.01.002","article-title":"Management of anemia associated with myelodysplastic syndrome","volume":"42","author":"Hellstrom-Lindberg","year":"2005","journal-title":"Semin Hematol"},{"key":"10.1016\/j.lpm.2017.10.007_bib0595","first-page":"128","article-title":"Iron overload is highly prevalent in all disease severity states in pyruvate kinase deficiency (PKD)","author":"van Beers","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.lpm.2017.10.007_bib0600","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1002\/pbc.25995","article-title":"Fanconi syndrome secondary to deferasirox in diamond-blackfan anemia: case series and recommendations for early diagnosis","volume":"63","author":"Papneja","year":"2016","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.lpm.2017.10.007_bib0605","first-page":"219","article-title":"Serum ferritin in patients with various haemolytic disorders","volume":"117","author":"Brabec","year":"1990","journal-title":"Folia Haematol Int Mag Klin Morphol Blutforsch"},{"key":"10.1016\/j.lpm.2017.10.007_bib0610","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/j.bbamcr.2012.01.014","article-title":"Hepcidin and iron homeostasis","volume":"1823","author":"Ganz","year":"2012","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"10.1016\/j.lpm.2017.10.007_bib0615","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/0016-5085(89)91642-9","article-title":"Iron overload complicating sideroblastic anemia\u2014Is the gene for hemochromatosis responsible","volume":"96","author":"Barron","year":"1989","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lpm.2017.10.007_bib0620","doi-asserted-by":"crossref","first-page":"443A","DOI":"10.1182\/blood.V108.11.1543.1543","article-title":"Ineffective erythropoiesis in beta-thalassemia is characterized by increased iron absorption mediated by down regulation of hepcidin and up regulation of ferroportin","volume":"108","author":"Gardenghi","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.lpm.2017.10.007_bib0625","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.mcna.2016.09.005","article-title":"Anemia of inflammation: a review","volume":"101","author":"Fraenkel","year":"2017","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.lpm.2017.10.007_bib0630","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.bbrc.2007.02.137","article-title":"ROS mediate the hypoxic repression of the hepcidin gene by inhibiting C\/EBP alpha and STAT-3","volume":"356","author":"Choi","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.lpm.2017.10.007_bib0635","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1172\/JCI31370","article-title":"Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs)","volume":"117","author":"Peyssonnaux","year":"2007","journal-title":"J Clin Investig"},{"key":"10.1016\/j.lpm.2017.10.007_bib0640","first-page":"789A","article-title":"Histone deacetylase inhibition restores hepcidin expression in Hcv replicon cells","volume":"48","author":"Miura","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.lpm.2017.10.007_bib0645","first-page":"1336","article-title":"Liver expression of hepcidin and other iron genes in two mouse models of beta-thalassemia","volume":"91","author":"De Franceschi","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.lpm.2017.10.007_bib0650","doi-asserted-by":"crossref","first-page":"667","DOI":"10.33549\/physiolres.930841","article-title":"Hepcidin mRNA levels in mouse liver respond to inhibition of erythropoiesis","volume":"55","author":"Vokurka","year":"2006","journal-title":"Physiol Res"},{"key":"10.1016\/j.lpm.2017.10.007_bib0655","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1365-2141.2011.08587.x","article-title":"Increased serum hepcidin levels during treatment with deferasirox in iron-overloaded patients with myelodysplastic syndrome","volume":"153","author":"Ghoti","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.lpm.2017.10.007_bib0660","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1182\/blood.V71.4.1124.1124","article-title":"The effect of erythroid hyperplasia on iron balance","volume":"71","author":"Pootrakul","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.lpm.2017.10.007_bib0665","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/nm1629","article-title":"High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin","volume":"13","author":"Tanno","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.lpm.2017.10.007_bib0670","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/ajh.23649","article-title":"Erythropoiesis-driven regulation of hepcidin in human red cell disorders is better reflected through concentrations of soluble transferrin receptor rather than growth differentiation factor 15","volume":"89","author":"Fertrin","year":"2014","journal-title":"Am J Hematol"},{"key":"10.1016\/j.lpm.2017.10.007_bib0675","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/ng.2996","article-title":"Identification of erythroferrone as an erythroid regulator of iron metabolism","volume":"46","author":"Kautz","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.lpm.2017.10.007_bib0680","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1042\/BJ20101825","article-title":"Regulation of cellular iron metabolism","volume":"434","author":"Wang","year":"2011","journal-title":"Biochem J"},{"key":"10.1016\/j.lpm.2017.10.007_bib0685","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0955-3886(00)00087-4","article-title":"The importance of non-transferrin bound iron in disorders of iron metabolism","volume":"23","author":"Breuer","year":"2000","journal-title":"Transfus Sci"},{"key":"10.1016\/j.lpm.2017.10.007_bib0690","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1182\/blood-2003-03-0807","article-title":"Labile plasma iron in iron overload: redox activity and susceptibility to chelation","volume":"102","author":"Esposito","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.lpm.2017.10.007_bib0695","doi-asserted-by":"crossref","first-page":"945289","DOI":"10.1155\/2011\/945289","article-title":"Uptake of non-transferrin iron by erythroid cells","volume":"2011","author":"Prus","year":"2011","journal-title":"Anemia"},{"key":"10.1016\/j.lpm.2017.10.007_bib0700","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0950-3536(05)80127-1","article-title":"Iron-metabolism in inflammation","volume":"7","author":"Konijn","year":"1994","journal-title":"Baillieres Clin Haematol"},{"key":"10.1016\/j.lpm.2017.10.007_bib0705","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1365-2141.2008.07192.x","article-title":"The labile iron pool in human erythroid cells","volume":"142","author":"Prus","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.lpm.2017.10.007_bib0710","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1182\/blood.V50.3.433.433","article-title":"Low-molecular weight intracellular iron transport compounds","volume":"50","author":"Jacobs","year":"1977","journal-title":"Blood"},{"key":"10.1016\/j.lpm.2017.10.007_bib0715","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1365-2141.1972.tb05682.x","article-title":"Slow rate of hemichrome formation from oxidized hemoglobin barts (Gamma4)\u2014Possible explanation for unequal quantities of hemoglobins H (Beta4) and barts in alpha-thalassemia","volume":"22","author":"Rachmilewitz","year":"1972","journal-title":"Br J Haematol"},{"key":"10.1016\/j.lpm.2017.10.007_bib0720","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1182\/blood.V79.4.1058.bloodjournal7941058","article-title":"Characterization and comparison of the red-blood-cell membrane damage in severe human alpha-thalassemia and beta-thalassemia","volume":"79","author":"Advani","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.lpm.2017.10.007_bib0725","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1172\/JCI107806","article-title":"Studies of hemoglobin denaturation and Heinz body formation in the unstable hemoglobins","volume":"54","author":"Winterbourn","year":"1974","journal-title":"J Clin Invest"},{"key":"10.1016\/j.lpm.2017.10.007_bib0730","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1258\/ebm.2010.009370","article-title":"Polyphenols enhance total oxidant-scavenging capacities of human blood by binding to red blood cells","volume":"235","author":"Koren","year":"2010","journal-title":"Exp Biol Med"},{"key":"10.1016\/j.lpm.2017.10.007_bib0735","first-page":"409","article-title":"Methods for evaluating iron stores and efficacy of chelation in transfusional hemosiderosis","volume":"76","author":"Borgnapignatti","year":"1991","journal-title":"Haematologica"},{"key":"10.1016\/j.lpm.2017.10.007_bib0740","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1182\/blood-2004-02-0630","article-title":"Labile plasma iron (LPI) as an indicator of chelatable plasma redox activity in iron-overloaded beta-thalassemia\/HbE patients treated with an oral chelator","volume":"104","author":"Pootrakul","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.lpm.2017.10.007_bib0745","first-page":"568","article-title":"Mass spectrometry-based hepcidin measurements in serum and urine: analytical aspects and clinical implications","volume":"82","author":"Kemna","year":"2007","journal-title":"Am J Hematol"},{"key":"10.1016\/j.lpm.2017.10.007_bib0750","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1053\/euhj.2001.2822","article-title":"Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload","volume":"22","author":"Anderson","year":"2001","journal-title":"Eur Heart J"},{"key":"10.1016\/j.lpm.2017.10.007_bib0755","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s10554-005-0651-2","article-title":"Intercentre reproducibility of magnetic resonance T2*measurements of myocardial iron in thalassaemia","volume":"21","author":"Westwood","year":"2005","journal-title":"Int J Cardiovasc Imaging"},{"key":"10.1016\/j.lpm.2017.10.007_bib0760","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/jmri.20379","article-title":"Left ventricular diastolic function compared with T2*cardiovascular magnetic resonance for early detection of myocardial iron overload in thalassemia major","volume":"22","author":"Westwood","year":"2005","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.lpm.2017.10.007_bib0765","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/mrm.21744","article-title":"Myocardial T-2* measurements in iron-overloaded thalassemia: an in vivo study to investigate optimal methods of quantification","volume":"60","author":"He","year":"2008","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.lpm.2017.10.007_bib0770","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1161\/CIRCULATIONAHA.104.504415","article-title":"Cardiac iron determines cardiac T2*, T2, and T1 in the gerbil model of iron cardiomyopathy","volume":"112","author":"Wood","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.lpm.2017.10.007_bib0775","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1182\/blood.V114.22.2004.2004","article-title":"Calibration of improved T2* method for the estimation of liver iron concentration in transfusional iron overload","volume":"114","author":"Garbowski","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.lpm.2017.10.007_bib0780","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1182\/blood-2003-06-1919","article-title":"Myocardial iron loading in transfusion-dependent thalassemia and sickle cell disease","volume":"103","author":"Wood","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.lpm.2017.10.007_bib0785","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.109.874487","article-title":"Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major","volume":"120","author":"Kirk","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.lpm.2017.10.007_bib0790","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0140-6736(03)12223-4","article-title":"Deferiprone versus desferrioxamine in thalassaemia, and T2*validation and utility","volume":"361","author":"Brittenham","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2017.10.007_bib0795","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/jmri.10396","article-title":"Interscanner reproducibility of cardiovascular magnetic resonance T2*measurements of tissue iron in thalassemia","volume":"18","author":"Westwood","year":"2003","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.lpm.2017.10.007_bib0800","first-page":"10","article-title":"Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance","author":"Modell","year":"2008","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.lpm.2017.10.007_bib0805","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1080\/01926230290166724","article-title":"Oxidation of biological systems: oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification","volume":"30","author":"Nyska","year":"2002","journal-title":"Toxicol Pathol"},{"key":"10.1016\/j.lpm.2017.10.007_bib0810","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0076-6879(90)86135-I","article-title":"Malondialdehyde determination as index of lipid-peroxidation","volume":"186","author":"Draper","year":"1990","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.lpm.2017.10.007_bib0815","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1046\/j.1365-2362.2002.0320s1055.x","article-title":"Oxidative status and malondialdehyde in beta-thalassaemia patients","volume":"32","author":"Cighetti","year":"2002","journal-title":"Eur J Clin Investig"},{"key":"10.1016\/j.lpm.2017.10.007_bib0820","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/cyto.a.20017","article-title":"Flow cytometric analysis of the oxidative status of normal and thalassemic red blood cells","volume":"60","author":"Amer","year":"2004","journal-title":"Cytometry A"},{"key":"10.1016\/j.lpm.2017.10.007_bib0825","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/cyto.a.20491","article-title":"Flow cytometry measurement of the labile iron pool in human hematopoietic cells","volume":"73","author":"Prus","year":"2008","journal-title":"Cytometry A"},{"key":"10.1016\/j.lpm.2017.10.007_bib0830","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/BF00368326","article-title":"Dihydrorhodamine 123: a new flow cytometric indicator for respiratory burst activity in neutrophil granulocytes","volume":"75","author":"Rothe","year":"1988","journal-title":"Naturwissenschaften"},{"key":"10.1016\/j.lpm.2017.10.007_bib0835","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/cyto.990090604","article-title":"A flow cytometric assay for intracellular nonprotein thiols using mercury orange","volume":"9","author":"O\u2019Connor","year":"1988","journal-title":"Cytometry"},{"key":"10.1016\/j.lpm.2017.10.007_bib0840","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ab.2009.06.011","article-title":"A flow cytometry approach for quantitative analysis of cellular phosphatidylserine distribution and shedding","volume":"393","author":"Freikman","year":"2009","journal-title":"Anal Biochem"},{"key":"10.1016\/j.lpm.2017.10.007_bib0845","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.3324\/haematol.2010.024992","article-title":"Changes in parameters of oxidative stress and free iron biomarkers during treatment with deferasirox in iron-overloaded patients with myelodysplastic syndromes","volume":"95","author":"Ghoti","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.lpm.2017.10.007_bib0850","doi-asserted-by":"crossref","DOI":"10.1002\/ajh.24668","article-title":"New film-coated tablet formulation of deferasirox is well tolerated in patients with thalassemia or lower-risk MDS: results of the randomized, phase II ECLIPSE study","author":"Taher","year":"2017","journal-title":"Am J Hematol"},{"key":"10.1016\/j.lpm.2017.10.007_bib0855","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1179\/2046905515Y.0000000040","article-title":"Safety profile of a liquid formulation of deferiprone in young children with transfusion-induced iron overload: a 1-year experience","volume":"36","author":"Chuansumrit","year":"2016","journal-title":"Paediatr Int Child Health"},{"key":"10.1016\/j.lpm.2017.10.007_bib0860","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1196\/annals.1345.014","article-title":"Role of iron in inducing oxidative stress in thalassemia. Cooley's Anemia Eighth Symposium","volume":"1054","author":"Rachmilewitz","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.lpm.2017.10.007_bib0865","first-page":"10","article-title":"Curcumin attenuates iron accumulation and oxidative stress in the liver and spleen of chronic iron-overloaded rats","author":"Badria","year":"2015","journal-title":"Plos One"},{"key":"10.1016\/j.lpm.2017.10.007_bib0870","first-page":"203","article-title":"The antioxidant effect of fermented papaya preparation involves iron chelation","volume":"26","author":"Prus","year":"2012","journal-title":"J Biol Regul Homeost Agents"},{"key":"10.1016\/j.lpm.2017.10.007_bib0875","first-page":"124","article-title":"Exogenous apo-transferrin increases monoferric transferrin, decreasing cytosolic iron uptake and heme and globin synthesis in beta-thalassemic mice","author":"Choesang","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.lpm.2017.10.007_bib0880","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1385\/SCR:1:3:197","article-title":"Leukemia-Stem cells, maturation arrest, and differentiation therapy","volume":"1","author":"Sell","year":"2005","journal-title":"Stem Cell Rev"},{"key":"10.1016\/j.lpm.2017.10.007_bib0885","first-page":"1033","article-title":"Targeting oxydative metabolism to treat leukemia?","volume":"26","author":"Callens","year":"2010","journal-title":"Med Sci"},{"key":"10.1016\/j.lpm.2017.10.007_bib0890","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1084\/jem.20091488","article-title":"Targeting iron homeostasis induces cellular differentiation and synergizes with differentiating agents in acute myeloid leukemia","volume":"207","author":"Callens","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/j.lpm.2017.10.007_bib0895","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1182\/blood-2011-12-399667","article-title":"Eltrombopag inhibits the proliferation of leukemia cells via reduction of intracellular iron and induction of differentiation","volume":"120","author":"Roth","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.lpm.2017.10.007_bib0900","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1517\/17425255.2013.858119","article-title":"Eltrombopag for the treatment of thrombocytopenia in patients with malignant and non-malignant hematologic disorders","volume":"9","author":"Pathak","year":"2013","journal-title":"Expert Opin Drug Metab Toxicol"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498217304566?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498217304566?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,7]],"date-time":"2022-08-07T23:34:19Z","timestamp":1659915259000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498217304566"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":90,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S0755498217304566"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2017.10.007","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Iron overload in hematological disorders","name":"articletitle","label":"Article Title"},{"value":"La Presse M\u00e9dicale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2017.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}